JPH0155416B2 - - Google Patents
Info
- Publication number
- JPH0155416B2 JPH0155416B2 JP57135952A JP13595282A JPH0155416B2 JP H0155416 B2 JPH0155416 B2 JP H0155416B2 JP 57135952 A JP57135952 A JP 57135952A JP 13595282 A JP13595282 A JP 13595282A JP H0155416 B2 JPH0155416 B2 JP H0155416B2
- Authority
- JP
- Japan
- Prior art keywords
- blood
- serum
- polyamine sulfone
- separating
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 210000004369 blood Anatomy 0.000 claims description 72
- 239000008280 blood Substances 0.000 claims description 72
- 210000002966 serum Anatomy 0.000 claims description 39
- 229920000768 polyamine Polymers 0.000 claims description 37
- 150000003457 sulfones Chemical class 0.000 claims description 37
- 208000007536 Thrombosis Diseases 0.000 claims description 26
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 21
- 239000000126 substance Substances 0.000 claims description 19
- 239000003463 adsorbent Substances 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 16
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 claims description 12
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 claims description 12
- 229920002079 Ellagic acid Polymers 0.000 claims description 12
- 238000009534 blood test Methods 0.000 claims description 12
- 229960002852 ellagic acid Drugs 0.000 claims description 12
- 235000004132 ellagic acid Nutrition 0.000 claims description 12
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 claims description 12
- 238000010521 absorption reaction Methods 0.000 claims description 10
- 235000021388 linseed oil Nutrition 0.000 claims description 9
- 239000000944 linseed oil Substances 0.000 claims description 9
- 239000000377 silicon dioxide Substances 0.000 claims description 9
- 229910052801 chlorine Inorganic materials 0.000 claims description 8
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 8
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 8
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 8
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 7
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 7
- 229910052794 bromium Chemical group 0.000 claims description 7
- 238000005119 centrifugation Methods 0.000 claims description 7
- 239000000460 chlorine Substances 0.000 claims description 7
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 7
- 239000002245 particle Substances 0.000 claims description 7
- 239000011521 glass Substances 0.000 claims description 5
- 239000005995 Aluminium silicate Substances 0.000 claims description 3
- 235000012211 aluminium silicate Nutrition 0.000 claims description 3
- 239000000440 bentonite Substances 0.000 claims description 3
- 229910000278 bentonite Inorganic materials 0.000 claims description 3
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 claims description 3
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 claims description 3
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 22
- 230000023555 blood coagulation Effects 0.000 description 22
- 229960002897 heparin Drugs 0.000 description 22
- 229920000669 heparin Polymers 0.000 description 22
- 238000012360 testing method Methods 0.000 description 12
- 102000009123 Fibrin Human genes 0.000 description 10
- 108010073385 Fibrin Proteins 0.000 description 10
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 10
- 229950003499 fibrin Drugs 0.000 description 10
- 230000001737 promoting effect Effects 0.000 description 10
- 229910010272 inorganic material Inorganic materials 0.000 description 9
- 239000011147 inorganic material Substances 0.000 description 9
- 238000000926 separation method Methods 0.000 description 8
- 239000007864 aqueous solution Substances 0.000 description 7
- 239000007789 gas Substances 0.000 description 7
- 238000001556 precipitation Methods 0.000 description 7
- 230000000694 effects Effects 0.000 description 6
- 102000015081 Blood Coagulation Factors Human genes 0.000 description 5
- 108010039209 Blood Coagulation Factors Proteins 0.000 description 5
- 108010080865 Factor XII Proteins 0.000 description 5
- 102000000429 Factor XII Human genes 0.000 description 5
- 239000003114 blood coagulation factor Substances 0.000 description 5
- 230000015271 coagulation Effects 0.000 description 5
- 238000005345 coagulation Methods 0.000 description 5
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 4
- 108090000190 Thrombin Proteins 0.000 description 4
- 230000004913 activation Effects 0.000 description 4
- 230000000274 adsorptive effect Effects 0.000 description 4
- 238000000502 dialysis Methods 0.000 description 4
- 229960004072 thrombin Drugs 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 229940019700 blood coagulation factors Drugs 0.000 description 3
- DYUWTXWIYMHBQS-UHFFFAOYSA-N n-prop-2-enylprop-2-en-1-amine Chemical compound C=CCNCC=C DYUWTXWIYMHBQS-UHFFFAOYSA-N 0.000 description 3
- 239000004745 nonwoven fabric Substances 0.000 description 3
- 229920013716 polyethylene resin Polymers 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 238000001179 sorption measurement Methods 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 108010049003 Fibrinogen Proteins 0.000 description 2
- 102000008946 Fibrinogen Human genes 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 description 2
- 238000010876 biochemical test Methods 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 230000001112 coagulating effect Effects 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 229940012952 fibrinogen Drugs 0.000 description 2
- 230000005484 gravity Effects 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 238000004904 shortening Methods 0.000 description 2
- CIHOLLKRGTVIJN-UHFFFAOYSA-N tert‐butyl hydroperoxide Chemical compound CC(C)(C)OO CIHOLLKRGTVIJN-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- LDCWGVLBCJEQMT-UHFFFAOYSA-N 2-methyl-n-(2-methylprop-2-enyl)prop-2-en-1-amine Chemical compound CC(=C)CNCC(C)=C LDCWGVLBCJEQMT-UHFFFAOYSA-N 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 108010000487 High-Molecular-Weight Kininogen Proteins 0.000 description 1
- 102100035792 Kininogen-1 Human genes 0.000 description 1
- 108010077861 Kininogens Proteins 0.000 description 1
- 102000010631 Kininogens Human genes 0.000 description 1
- 108090000113 Plasma Kallikrein Proteins 0.000 description 1
- 108010094028 Prothrombin Proteins 0.000 description 1
- 102100027378 Prothrombin Human genes 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 229910001870 ammonium persulfate Inorganic materials 0.000 description 1
- 239000004019 antithrombin Substances 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 230000009918 complex formation Effects 0.000 description 1
- 238000010908 decantation Methods 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- 229910001882 dioxygen Inorganic materials 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 239000002612 dispersion medium Substances 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000002685 polymerization catalyst Substances 0.000 description 1
- 230000020971 positive regulation of blood coagulation Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 229940039716 prothrombin Drugs 0.000 description 1
- 238000010526 radical polymerization reaction Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- -1 t-butyloxy group Chemical group 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5002—Partitioning blood components
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP57135952A JPS5926062A (ja) | 1982-08-03 | 1982-08-03 | 血清と血餅との分離方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP57135952A JPS5926062A (ja) | 1982-08-03 | 1982-08-03 | 血清と血餅との分離方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5926062A JPS5926062A (ja) | 1984-02-10 |
| JPH0155416B2 true JPH0155416B2 (fr) | 1989-11-24 |
Family
ID=15163672
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP57135952A Granted JPS5926062A (ja) | 1982-08-03 | 1982-08-03 | 血清と血餅との分離方法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5926062A (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4406981A1 (fr) | 2021-09-21 | 2024-07-31 | Nitto Boseki Co., Ltd. | Agent de séparation des cellules sanguines pour l'analyse et procédé de séparation des cellules sanguines |
| CN118076891A (zh) | 2021-09-21 | 2024-05-24 | 日东纺绩株式会社 | 血细胞分离剂及使用其的血细胞分离方法 |
-
1982
- 1982-08-03 JP JP57135952A patent/JPS5926062A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5926062A (ja) | 1984-02-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Liu et al. | Surface characteristics and hemocompatibility of PAN/PVDF blend membranes | |
| US5407581A (en) | Filter medium having a limited surface negative charge for treating a blood material | |
| KR930011033B1 (ko) | 진공 채혈관 | |
| CN116510696B (zh) | 一种吸附血红蛋白的水凝胶及其制备方法 | |
| JPH105329A (ja) | 直接血液灌流に用いる吸着体用担体およびその小粒径化法 | |
| Yin et al. | Molecularly-imprinted hydrogel beads via self-sacrificing micro-reactors as safe and selective bilirubin adsorbents | |
| GB1560556A (en) | Coated activated carbon beads for purifying blood | |
| Deng et al. | Poly (ether sulfone)/activated carbon hybrid beads for creatinine adsorption | |
| JPH0155416B2 (fr) | ||
| GB2025385A (en) | Activated carbon and apparatus for hemoperfusion | |
| Cheung | Adsorption of unactivated complement proteins by hemodialysis membranes | |
| Alula et al. | Preparation characterization and blood compatibility studies of silk fibroin/gelatin/curcumin injectable hydrogels | |
| CN113817712B (zh) | 凝血酶的制备方法 | |
| JP5424688B2 (ja) | 顆粒球及び単球の選択的除去材 | |
| JP3633979B2 (ja) | エンドトキシンの吸着剤、吸着除去方法および吸着器 | |
| JPH0126502B2 (fr) | ||
| JPS58196457A (ja) | 血清と血餅との分離方法 | |
| Denizli et al. | Competitive adsorption of blood proteins on gamma-irradiated-polycarbonate films | |
| JPH039421B2 (fr) | ||
| Schultze et al. | Formation of thrombin-antithrombin III complex using polyamide and hemophan dialyzers | |
| JP4779190B2 (ja) | 炎症性疾患治療用カラム | |
| JP3633978B2 (ja) | 腫瘍壊死因子−αの吸着剤、吸着除去方法および吸着器 | |
| JPS58195151A (ja) | 血液検査用容器 | |
| JP4402236B2 (ja) | リポ蛋白質の吸着除去方法 | |
| JPS58143267A (ja) | 血液検査用容器 |